Introduction
============

Acute coronary syndromes (ACS), defined as ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation MI (NSTEMI), and unstable angina (UA), cause significant morbidity and mortality in industrialized societies [@bib1]. Growing evidence from clinical studies using case cross-over analysis suggests that acute episodes of anger can trigger ACS in people with advanced coronary disease, with the period 1--2 h prior to symptom onset being particularly hazardous [@bib2; @bib3; @bib4; @bib5].

Hostility is an enduring personality trait that includes emotional (anger) as well as attitudinal (cynicism and mistrust of others) and behavioral (overt and repressed aggression) components [@bib6], and numerous cross-sectional and prospective studies have highlighted hostility as a robust independent risk factor for coronary artery disease (CAD) and all-cause mortality in humans [@bib7; @bib8; @bib9; @bib10; @bib11]. Findings relating hostility with adverse clinical outcomes in CAD patients have been somewhat less consistent [@bib12]. However, a recent meta-analysis including 19 prospective studies of men and women with existing coronary disease found a significant independent association between hostility and risk of future cardiac events in these patients [@bib11].

The pathophysiological mechanisms underlying emotional triggering of acute cardiac events are poorly understood. Atherosclerosis is a chronic inflammatory process involving the progressive recruitment and activation of leukocytes, lipid, platelets, and smooth muscle cells in the endothelial lining of coronary arteries, resulting in the formation of a fibrous plaque that protrudes into the arterial lumen. ACS occur when there is a rupture of vulnerable plaque and consequent activation and aggregation of platelets, leading to the formation of a blood clot (thrombus) that occludes the artery and prevents blood flow to the heart [@bib13]. Emotional stress activates the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal axis, resulting in respective increases in blood pressure (BP) and circulating levels of catecholamines and glucocorticoids (cortisol) [@bib14]. Acute elevations in BP can provoke plaque rupture by disrupting blood flow across the diseased vessel and increasing endothelial shear stress [@bib15], and glucocorticoids regulate a number of processes involved in plaque stability including vascular endothelial function and inflammation [@bib16]. Circulating levels of inflammatory cytokines are also up-regulated during stress, and these molecules play a pivotal role in plaque rupture and thrombosis [@bib15; @bib17].

There is considerable evidence that healthy hostile individuals have heightened or prolonged cardiovascular and neuroendocrine responses to acute emotional stress [@bib18]. However, studies relating hostility and inflammatory stress responses are sparse. Furthermore, little is known about the role of hostility in acute stress responses in patients with advanced cardiovascular disease. We set out to address these issues by investigating the relationship between trait hostility and physiological responses to laboratory stress in a sample of patients who had recently survived an ACS. We predicted that patients with elevated hostility scores would be more responsive to stress.

Methods
=======

Participants
------------

Thirty-four men who had recently survived an ACS were included in this study, details of which are reported elsewhere [@bib19]. Participants were a subsample from the ACCENT study, an investigation of 295 patients admitted with ACS to four hospitals in the London area [@bib5]. Inclusion criteria for the ACCENT study were as follows: a diagnosis of ACS based on the presence of chest pain plus verification by diagnostic electrocardiogram (EKG) and/or cardiac enzyme changes; the ability to recall a specific time of symptom onset and to complete a research interview in English; age between 18 and 90 years; and the absence of comorbid conditions that could influence either symptom presentation, mood, or troponin positivity (including severe psychiatric illness, ongoing infection, or inflammatory conditions). Patients were classified on the basis of EKG and biochemical markers to the different forms of ACS. Primary treatments were classified as percutaneous coronary intervention (PCI), medical, or coronary artery bypass graft (CABG).

For the current experiment, patients were recruited on average 444.9±172 days post-ACS. This time interval was selected to ensure that the patients\' clinical condition had stabilized. Patients who had experienced a second ACS or cardiac intervention during the previous 6 months or had severely impaired left ventricular function (\<40%) or ongoing symptoms of chest pain or breathlessness were excluded. Patients who were aged over 80, were hypertensive, taking antidepressants, color blind, had a history of late ventricular dysrhythmia, atrial fibrillation, or developed new comorbidities that could affect hemodynamic or inflammatory measures were also excluded. Since the ACCENT study included an insufficient number of women, only men were included in the current investigation. There were 231 men in the ACCENT study, of whom three were \>80 years old, and 21 experienced onset of ACS after they had been asleep for at least 2 h, so could not provide information about the circumstances surrounding ACS onset, an additional focus of our research [@bib19]. Of the remainder, 12 lived outside the country or too far away for participation; 50 were hypertensive; five were deceased; 14 were lost to follow-up; 44 had relevant comorbidities, persisting symptoms, or very poor left ventricular function; and one was blind. Of the 82 subjects eligible for participation, 34 were tested in the time available to complete the study. Patients who participated in psychophysiological stress testing were younger on average than those who were excluded (*P*=.023) but did not differ in clinical presentation, medical management, number of diseased coronary arteries, or other cardiological or sociodemographic characteristics. All patients gave written consent, and the study was approved by the medical research ethics committees of University College London Hospital, St. George\'s Hospital, and Southend Hospital, in London.

Psychological measures
----------------------

Hostility was measured using a 39-item abbreviated version of the Cook Medley Hostility Scale (CMHS) [@bib6]. The CMHS is the most widely used self-reported measure of hostility and is reported to have good psychometric properties including adequate internal validity, good test--retest reliability, and construct validity [@bib20; @bib21]. Each item was scored on a four-point scale from 1=*strongly disagree* to 4=*strongly agree*, and measured trait tendencies towards cynical, mistrustful attitudes towards others, and, to a lesser extent, the individual\'s propensity for aggressive responding and experiencing hostile affects. Total scores could range from 39 to 156, with higher scores indicating greater hostility, and the Cronbach *α* in this sample was 0.90. Anxiety and depression were assessed using the Hospital Anxiety and Depression scale, a well-validated instrument specifically designed to assess mood in medical patients [@bib22]. Each scale consists of seven items rated on four-point scales, and total scores can range from 0 to 21. Cronbach *α* scores were 0.80 and 0.77 for the anxiety and depression scales, respectively.

Laboratory stress testing procedure
-----------------------------------

Participants were tested individually in the morning, commencing at 9 a.m. They were instructed to avoid eating a high-fat or high-protein breakfast, and to refrain from caffeinated beverages, alcohol, and excessive exercise during the 12 h prior to the session. Following consultation with physicians, 18 patients were withdrawn from medication prior to the session and stopped taking aspirin 10 days before testing and β-blockers, statins, or angiotensin-converting enzyme (ACE) inhibitors 72 h before testing. The remaining 16 continued to take some form of medication at the time of testing ([Table 1](#tbl1){ref-type="table"}).

Anthropometric measures were obtained using standardized methods, then participants were seated comfortably and fitted with finger cuffs so that BP and heart rate could be continuously monitored using a Portapres-2 device (TNO-TPD Biomedical Instrumentation, Amsterdam, Holland) [@bib23]. A venous cannula was inserted in the lower arm for blood sampling, and the participant rested for 30 min. Blood pressure and heart rate were recorded for the last 5 min of the rest period, after which participants provided a salivary cortisol sample, and a baseline blood sample was drawn. Participants then completed two 5-min behavioral tasks, administered in a fixed order. The first was a computerized color-word interference task, involving the successive presentation of target color words printed in an incongruous color. The task was to press a computer key that corresponded to the position at the bottom of the screen of the name of the color in which the target word was printed. The second task was presented after an interval of 5 min and involved simulated public speaking. Participants were presented with a hypothetical scenario in which they had been wrongly accused of shoplifting and were instructed to give a speech in their defense. They were told that their speech would be video recorded and later judged for efficacy and fluency. Five-minute recordings of BP and heart rate were made during each of the tasks, and a second cortisol and blood sample were obtained immediately after the second task. Participants then rested quietly for the remainder of the session. They were asked to rate subjective feelings of stress on a seven-point scale from 1=*low* to 7=*high* at baseline (towards the end of the rest period), following each of the tasks and then at 25, 70, and 115 min post-task. Ratings of task difficulty, controllability, and involvement were also made after each task on seven-point scales. Further recordings of BP and heart rate were made at 25--30, 70--75, and 115--120 min post-tasks, and blood samples were obtained at 30, 75, and 120 min post-tasks. Salivary cortisol was sampled at 15, 30, 75, and 120 min post-tasks.

Cortisol measurement
--------------------

Saliva samples were collected using Salivettes (Sarstedt, Leicester, UK) and stored at −80°C prior to analyses. Salivary cortisol was analyzed in randomized, duplicate samples using a commercially available time-resolved immunoassay with chemiluminescence detection (CLIA; IBL-Hamburg, Hamburg, Germany), at the Technical University of Dresden, Germany. This assay had a detection limit of 0.16 ng/ml and intra- and interassay coefficients of variation (CVs) of \<10% and \<12%, respectively. The experimenter performing the assay was blinded to participant details. Salivary cortisol levels are highly correlated with circulating levels of free cortisol and are routinely used as a biomarker of psychological stress [@bib24].

Interleukin-6 measurement
-------------------------

Whole blood (10 ml) samples were drawn using 21-gauge Butterfly needles into Vacutainer tubes containing EDTA as anticoagulant, then centrifuged immediately at 1250×*g* for 10 min at room temperature. Plasma was removed, aliquoted, and frozen at −80°C prior to analysis. Plasma interleukin-6 (IL-6) concentrations were assessed in randomized, duplicate samples using a high-sensitivity two-site ELISA from R&D Systems (Oxford, UK). The detection limit of this assay was 0.09 pg/ml, with intra- and interassay CVs of 5.3% and 9.2%, respectively. The experimenter running this assay was blinded to participant details.

Statistical analyses
--------------------

All analyses were performed using SPSS version 14.0 (SPSS, Chicago, IL, USA). Some data were lost due to equipment or assay failures, so analyses were performed on 32 patients for cortisol and 31 patients for BP, heart rate, and IL-6. Other variables were measured in all 34 participants. Responses to mental stress testing were analyzed using repeated measures analysis of variance, with post hoc comparisons using Tukey\'s LSD test. Cardiovascular variables were analyzed across five trials (baseline, task, 30 min, 75 min, and 120 min), IL-6 across four trials (baseline, 30 min, 75 min, and 120 min post-task), and cortisol across six trials (baseline; immediately post-task; and 15, 30, 75, and 120 min post-task). Associations with hostility were analyzed using multiple regression. For baseline measures, hostility was entered into the regression models along with age, BMI, smoking status, and medication status as covariates. The use of medications was overlapping, since all patients who were taking aspirin, statins, or ACE inhibitors were also taking β-blockers. Consequently, medication status was indexed by the use of β-blockers. Replacing BMI with waist/hip ratio as an indicator of adiposity did not alter the results. Associations of hostility with stress reactivity and recovery involved regressions onto changes between baseline and task or post-task values, and included the baseline level of the dependent variable as an additional covariate. All tests were two tailed.

Results
=======

Participant characteristics
---------------------------

Participant characteristics are presented in [Table 1](#tbl1){ref-type="table"}. Men in this study had a mean age of 55.9 (S.D. 9.3). They were predominantly white, with a limited education level. A significant number were overweight and approximately one fifth smoked. Twenty-four participants (70.6%) were admitted with STEMI and the remainder with NSTEMI or UA. Several participants continued to take medication at the time of testing with just under half on β-blockers, around a quarter on ACE inhibitors, and approximately one third on statins or aspirin. Participants\' mean score on the CMHS was 91.0 (S.D. 11.8). Hostility was not related to age, education level, ethnicity, BMI, waist--hip ratio, or smoking status, nor was it related to clinical variables including type of ACS, number of diseased vessels, treatment plan, or medication status at the time of testing. Hostility scores were positively correlated with depression (*r*=0.38, *P*=.029) but not with anxiety (*r*=0.22, *P*=.23).

Stress responses
----------------

Details of participants\' subjective and physiological stress responses are presented in [Table 2](#tbl2){ref-type="table"}. Participants rated both tasks as difficult and involving, with mean ratings of 5.26±1.3 and 5.35±1.4, respectively, for the color-word and 4.50±1.4 and 4.38±1.9 for the speech task. There were significant main effects of trial for perceived stress levels \[*F*(4,128)=63.6, *P*\<.001\], systolic BP \[*F*(4,120)=32.3, *P*\<.001\], diastolic BP \[*F*(4,120)=25.4, *P*\<.001\], heart rate \[*F*(4,116)=50.4, *P*\<.001\], and cortisol \[*F*(5,155)=19.1, *P*\<.001\]. Perceived stress levels increased during each of the tasks, returning to low levels during recovery. Participants\' BP also increased significantly during tasks, with an average rise of 33.3±18.8 mmHg in systolic BP and 16.8±9.4 mmHg in diastolic BP, respectively. Both systolic and diastolic BP remained elevated above baseline levels during the 2-h recovery period. Similarly, heart rate increased substantially in response to tasks, with an average rise of 8.2±5.5 bpm. There were large individual differences in cardiovascular stress responses with changes in systolic BP ranging from −17.8 to +73.91 mmHg during tasks and from −19.8 to +29.9 mmHg at 2 h post-task. Similarly, diastolic BP responses ranged from −5.11 to +42.6 mmHg during tasks. Salivary cortisol levels increased following tasks, peaking at 15 min post-task. Although the average increase in plasma IL-6 was not significant, there were marked individual differences in this response, with changes in IL-6 ranging from −1.38 to +1.56 pg/ml at 75 min and −1.34 to +1.68 pg/ml at 120 min poststress. There were no significant associations between IL-6 measures and any of the cardiovascular responses. However, there was an inverse relationship between cortisol and IL-6 responses; the cortisol change at 75 min was inversely correlated with increases in IL-6 at 75 min (*r*=−0.49, *P*=.009) and 120 min (*r*=−0.51, *P*=.006).

Relationship between trait hostility and subjective and physiological parameters
--------------------------------------------------------------------------------

There was no association between hostility and baseline levels of subjective stress, BP, heart rate, salivary cortisol, or plasma IL-6 concentrations. However, multiple regression analysis revealed a significant relationship between trait hostility and systolic BP reactivity to tasks (*β*=0.358, *P*=.048). The variance accounted for by the complete model (*r*^2^) was 0.32, and the variance accounted for by hostility (Δ*r*^2^) was 0.11. A similar relationship was found between hostility and diastolic BP reactivity to tasks (*β*=0.476, *P*=.007, *r*^2^=0.37, Δ*r*^2^=0.21). These associations, illustrated in [Fig. 1](#fig1){ref-type="fig"}, were independent of age, BMI, smoking status, medication at the time of testing, and baseline levels of the respective dependent variable. Hostility was not related to either heart rate reactivity or cortisol reactivity.

Regression analyses also revealed a significant association between hostility and prolonged increases in systolic BP at 2 h post-task (*β*=0.400, *P*=.024, *r*^2^=.38, Δ*r*^2^=0.15) and between hostility and elevated plasma IL-6 concentrations at both 75 min post-task (*β*=0.309, *P*=.023, *r*^2^=.63, Δ*r*^2^=0.09) and 2 h post-task (*β*=0.327, *P*=.016, *r*^2^=.64, Δ*r*^2^=0.10). By contrast, hostility was negatively correlated with cortisol levels at 75 min post-task (*β*=−0.325, *P*=.034, *r*^2^=.64, Δ*r*^2^=0.10) and was unrelated to heart rate recovery. As above, all associations were independent of age, BMI, smoking status, medication at the time of testing, and baseline levels of the respective dependent variable. The relationship between hostility and IL-6 responses is illustrated in [Fig. 2](#fig2){ref-type="fig"}, showing larger increases in IL-6 at 75 and 120 min post-task in more hostile individuals.

There was no association between hostility and subjective task appraisal, or ratings of perceived stress, or between subjective stress responses and BP or cytokine responses, indicating that heightened/prolonged stress reactivity in high-hostile men was not due to differences in the subjective experience of the tasks. Similarly, depression and anxiety had no impact on the associations between hostility and biological responses (data not shown).

Discussion
==========

One of the main findings of our study was that ACS patients scoring higher on the CMHS had larger increases in systolic and diastolic BP during acute laboratory stress, as well as a sustained increase in systolic BP following cessation of the stress. These results add to the large body of previous research demonstrating excessive and prolonged cardiovascular reactivity to stressful situations among healthy hostile individuals. Specifically, studies have shown that high hostile men and women display larger increases in BP and heart rate as well as elevated circulating levels of catecholamines, during and following exposure to acute laboratory stressors [@bib18; @bib25; @bib26; @bib27]. Our study extends these observations to a diseased patient sample.

The other main study finding was that hostile ACS patients had heightened poststress levels of IL-6. This suggests that hostility may promote inflammation, although the cross-sectional design prevents causal conclusions from being drawn. A number of previous reports have found positive correlations between hostility and basal circulating levels of IL-6 in healthy humans. Total CMHS scores were associated with elevated plasma IL-6 concentrations in a small study of healthy men [@bib28]. More recently, a larger cross-sectional analysis of 6814 adults aged 45--84 years found a positive graded relationship between serum IL-6 and scores of cynical distrust, a component of hostility assessed using a subscale of the CMHS [@bib29], and comparable associations were observed between circulating IL-6 and scores on the hostile affect, cynicism, and aggressive responding subscales of the CMHS in samples of middle-aged men and women [@bib30; @bib31]. However, results have been variable, with some studies reporting no association between hostility and IL-6 levels in healthy adults [@bib32], and others reporting an association only in individuals with concurrently high or low levels of depressive symptoms [@bib33; @bib34; @bib35]. In the present investigation, hostility was unrelated to basal IL-6 concentrations and the association between hostility and IL-6 stress responses was independent of depressive symptoms. Differences between study findings may be due to heterogeneity in the hostility measure used, the specific population studied and/or the presence of other moderating psychosocial factors. To our knowledge, only one previous investigation has examined the relationship between hostility and inflammatory stress responses. Kiecolt-Glaser et al. [@bib36] found that couples with a high frequency of hostile marital interactions, 'high-hostile couples', developed larger increases in plasma levels of IL-6 and TNFα the morning after a conflictual interaction task, compared with low-hostile couples. Supporting our findings, these results suggest that hostile individuals may be more susceptible to stress-induced inflammation.

The mechanisms driving the association between hostility and acute stress responses are unclear. Excessive sympathetic nervous activity has been linked to β-adrenergic receptor (β-AR) down-regulation in animals, and a number of studies have related hostility to blunted cardiac and vascular β-AR sensitivity in humans [@bib37; @bib38]. Since β-AR activation plays a central role in the healthy vasodilatory response of blood vessels to stress, a blunted adrenergic response, promoting vasoconstriction, would result in an increase in total peripheral resistance and elevated BP. There is also evidence for diminished stress-induced parasympathetic nervous activity in hostile individuals, and this 'autonomic imbalance' likely contributes to heightened cardiovascular reactivity, due to a reduction in cardiac autonomic control [@bib27; @bib39]. Lastly, glucocorticoids inhibit inflammatory cytokine production by monocytes [@bib16] and evidence suggests that high cortisol responders have smaller inflammatory cytokine responses to acute psychological stress [@bib40]. In the current investigation, hostile patients had lower cortisol levels at 75 min poststress, and cortisol responses were inversely related to IL-6 stress responses. Thus diminished cortisol levels in hostile patients might also facilitate a heightened inflammatory response.

Prospective evidence in healthy humans has shown that heightened and/or prolonged BP reactivity to acute laboratory stress is predictive of future hypertension and progression of preclinical cardiovascular disease states [@bib41; @bib42]. However, the data relating acute stress reactivity with clinical CAD are less convincing, and most studies in healthy individuals have found no relationship between BP responses and future cardiac events or mortality [@bib41]. Acute cardiovascular and inflammatory stress responses may be more relevant in people with advanced cardiovascular disease. Evidence suggests that, whereas healthy coronary vessels dilate in response to stress-induced SNS activation, atherosclerotic vessels constrict, leading to increased peripheral vascular resistance and myocardial ischemia [@bib43]. In addition, IL-6 stimulates a number of key processes that contribute to plaque rupture and thrombosis including macrophage production of matrix metalloproteinases (enzymes that degrade the plaque\'s protective fibrous cap), monocyte production of tissue factor (a key initiator of blood coagulation in ACS), and hepatic synthesis of fibrinogen (an acute phase protein central to blood coagulation and platelet aggregation) [@bib13; @bib44]. Plasma IL-6 levels are significantly elevated in ACS patients compared to patients with stable CAD or healthy age-matched controls [@bib45; @bib46], and blood IL-6 levels assessed at or near to the time of hospital admission are a significant independent predictor of subsequent coronary events and mortality [@bib46; @bib47].

The number of patients suitable for this investigation was limited and the sample size was small. We therefore decided not to randomize patients to stress and control conditions but to apply the stressors to all participants. We and others have previously shown that repeated measurements or the passage of time in the absence of behavioral tasks does not lead to elevations of cardiovascular and inflammatory markers [@bib15; @bib17]. Nevertheless, it would have been preferable to include a comparison control group of healthy individuals without ACS, to test whether our observed associations between hostility and stress responses were specific to (or strengthened by) the presence of advanced CAD. The majority of participants were poorly educated men of white European origin, and results may not apply to other groups. Several were overweight and current smokers, and the analysis was complicated by the inclusion of patients whose medications had been withdrawn and those individuals who continued to take medication at the time of testing. A number of previous studies examining the effects of medication on physiological stress reactivity in humans found no effect of aspirin or β-blockers on either cardiovascular or cortisol responses to stress [@bib48; @bib49; @bib50]. However, one recent study showed that aspirin attenuated IL-6 stress responses [@bib49] and an effect of medication on stress reactivity cannot be excluded. Due to the cross-sectional nature of our study, the directionality of the relationship between hostility and cardiovascular and cytokine responses cannot be determined. The laboratory tasks used were not optimal for evoking anger, and it would have been useful to include a measure of state anger, given the evidence relating anger and emotional triggering of ACS. Lastly, the CMHS is a self-report measure and there is evidence that other hostility measures such as behavioral ratings or ratings by significant others may have more predictive utility in studies relating personality and cardiovascular risk [@bib9; @bib51].

To our knowledge, this is the first study to directly associate hostility with inflammatory and cardiovascular stress responses in ACS patients. Our findings indicate that hostile individuals with advanced cardiovascular disease are particularly susceptible to stress-induced increases in sympathetic activity and inflammation. These mechanisms may contribute to an elevated risk of emotionally triggered cardiac events in such patients.
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###### 

Participant characteristics (*N*=34)

  ----------------------------------- -------------
  Age                                 55.9±9.3
  Ethnicity (white European)          29 (85.3 %)
  Education level                     
   Less than high school              22 (64.7%)
   High school, college               12 (35.3%)
  Body mass index (kg/m^2^)           29.4±4.1
  Waist--hip ratio                    1.01±0.51
  Cook Medley Hostility               91.0±11.8
  Depression                          3.88±3.3
  Anxiety                             5.03±3.4
  Current smokers                     7 (20.6%)
  Number of diseased vessels          1.5±0.79
  ACS                                 
   STEMI                              24 (70.6%)
   NSTEMI and UA                      10 (29.4%)
  Treatment                           
   Medical                            5 (15.2%)
   PCI                                23 (69.7%)
   CABG                               5 (15.2%)
  β-Blockers at time of testing       16 (47.1%)
  Statins at time of testing          11 (32.4%)
  ACE inhibitors at time of testing   8 (23.5%)
  Aspirin at time of testing          11 (32.4%)
  ----------------------------------- -------------

Values are means±standard deviations, and numbers (percentages) for categorical variables.

###### 

Cardiovascular, inflammatory, and subjective stress responses

                             Baseline       Tasks          Immediately post-task   15 min post-task   30 min post-task   75 min post-task   120 min post-task
  -------------------------- -------------- -------------- ----------------------- ------------------ ------------------ ------------------ -------------------
  Systolic BP (mmHg)         118.6±3.8^a^   151.9±4.3^b^                                              133.0±4.3^c^       135.0±4.3^c^       128.0±4.1^c^
  Diastolic BP (mmHg)        74.7±2.0^a^    91.5±2.2^b^                                               84.0±2.1^c^        85.3±2.2^c^        82.5±2.2^c^
  Heart rate (bpm)           62.8±1.9^a^    71.0±2.2^b^                                               61.1±1.8^c^        61.4±1.7^c^        60.6±1.7^c^
  IL-6 (pg/ml)               1.96±0.21^a^                                                             2.16± 0.23^a^      2.30±0.28^a^       2.23±0.24^a^
  Cortisol (nmol/l)          7.99±0.81^a^                  10.38±1.1^b^            13.36±1.6^c^       8.98±0.95^a,b^     5.30±0.42^d^       5.36±0.62^d^
  Subjective stress rating   1.61±0.16^a^   3.77±0.17^b^                                              1.61±0.16^a^       1.30±0.13^a^       1.39±0.17^a^

Values are means±S.E. Stress responses were analyzed using repeated measures analysis of variance, with post hoc comparisons using Tukey\'s LSD test. Trials in rows with different superscripts are significantly different from one another (*P*\<.05).
